Comparison of Rocuronium and Org 25969 With Cisatracurium and Neostigmine (19.4.310)(P05931)
Clinical trial NCT00451100 · COMPLETED
Trial details
- NCT number
- NCT00451100
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-11-10
- Primary completion
- 2006-05-22
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.